(Q43430302)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12633691%20AND%20SRC:MED&resulttype=core&format=json

1 November 2019

title

Long-term results of CMV hyperimmune globulin prophylaxis in 377 heart transplant recipients (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12633691%20AND%20SRC:MED&resulttype=core&format=json

1 November 2019

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12633691%20AND%20SRC:MED&resulttype=core&format=json

1 November 2019

author name string

Alfred A Kocher

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12633691%20AND%20SRC:MED&resulttype=core&format=json

1 November 2019

Nikolaos Bonaros

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12633691%20AND%20SRC:MED&resulttype=core&format=json

1 November 2019

Marek Ehrlich

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12633691%20AND%20SRC:MED&resulttype=core&format=json

1 November 2019

Bernhard Schlechta

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12633691%20AND%20SRC:MED&resulttype=core&format=json

1 November 2019

Barbara Zweytick

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12633691%20AND%20SRC:MED&resulttype=core&format=json

1 November 2019

Michael Grimm

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12633691%20AND%20SRC:MED&resulttype=core&format=json

1 November 2019

Andreas Zuckermann

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12633691%20AND%20SRC:MED&resulttype=core&format=json

1 November 2019

Ernst Wolner

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12633691%20AND%20SRC:MED&resulttype=core&format=json

1 November 2019

Guenther Laufer

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12633691%20AND%20SRC:MED&resulttype=core&format=json

1 November 2019

publication date

1 March 2003

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12633691%20AND%20SRC:MED&resulttype=core&format=json

The Journal of Heart and Lung Transplantation

1 November 2019

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12633691%20AND%20SRC:MED&resulttype=core&format=json

1 November 2019

volume

22

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12633691%20AND%20SRC:MED&resulttype=core&format=json

1 November 2019

issue

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12633691%20AND%20SRC:MED&resulttype=core&format=json

1 November 2019

page(s)

250-257

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12633691%20AND%20SRC:MED&resulttype=core&format=json

Infections in heart transplant recipients

1 November 2019

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS1053-2498%2802%2900474-6

7 January 2021

Cytomegalovirus infection after organ transplantation: an update with special emphasis on renal transplantation

1 reference

https://api.crossref.org/works/10.1016%2FS1053-2498%2802%2900474-6

7 January 2021

The indirect effects of cytomegalovirus infection on the outcome of organ transplantation

1 reference

https://api.crossref.org/works/10.1016%2FS1053-2498%2802%2900474-6

7 January 2021

Cytomegalovirus disease and allograft loss after organ transplantation

1 reference

https://api.crossref.org/works/10.1016%2FS1053-2498%2802%2900474-6

7 January 2021

Gastric mucosal nodules due to cytomegalovirus infection

1 reference

https://api.crossref.org/works/10.1016%2FS1053-2498%2802%2900474-6

7 January 2021

Viral pneumonias. Infection in the immunocompromised host

1 reference

https://api.crossref.org/works/10.1016%2FS1053-2498%2802%2900474-6

7 January 2021

Is cytomegalovirus interstitial pneumonitis in transplant recipients an immunopathological condition?

1 reference

https://api.crossref.org/works/10.1016%2FS1053-2498%2802%2900474-6

7 January 2021

Infections Due to Herpesviruses in Cardiac Transplant Recipients: Role of the Donor Heart and Immunosuppressive Therapy

1 reference

https://api.crossref.org/works/10.1016%2FS1053-2498%2802%2900474-6

7 January 2021

Cytomegalovirus myocarditis

1 reference

https://api.crossref.org/works/10.1016%2FS1053-2498%2802%2900474-6

7 January 2021

Cytomegalovirus myocarditis

1 reference

https://api.crossref.org/works/10.1016%2FS1053-2498%2802%2900474-6

7 January 2021

Spectrum of neurologic events following cardiac transplantation

1 reference

https://api.crossref.org/works/10.1016%2FS1053-2498%2802%2900474-6

7 January 2021

Cytomegalovirus retinitis after cardiac transplantation

1 reference

https://api.crossref.org/works/10.1016%2FS1053-2498%2802%2900474-6

7 January 2021

New strategies for prevention and therapy of cytomegalovirus infection and disease in solid-organ transplant recipients

1 reference

https://api.crossref.org/works/10.1016%2FS1053-2498%2802%2900474-6

7 January 2021

Reactivation and recombination of multiple cytomegalovirus strains from individual organ donors

1 reference

https://api.crossref.org/works/10.1016%2FS1053-2498%2802%2900474-6

7 January 2021

Cytomegalovirus nucleic acids in allografted hearts

1 reference

https://api.crossref.org/works/10.1016%2FS1053-2498%2802%2900474-6

7 January 2021

Reducing the Risk for Transfusion-transmitted Cytomegalovirus Infection

1 reference

https://api.crossref.org/works/10.1016%2FS1053-2498%2802%2900474-6

7 January 2021

Cytomegalovirus immune globulin and seronegative blood products to prevent primary cytomegalovirus infection after marrow transplantation

1 reference

https://api.crossref.org/works/10.1016%2FS1053-2498%2802%2900474-6

7 January 2021

Blood cyclosporine concentrations and cytomegalovirus infection following heart transplantation

1 reference

https://api.crossref.org/works/10.1016%2FS1053-2498%2802%2900474-6

7 January 2021

Molecular mimicry: frequency of reactivity of monoclonal antiviral antibodies with normal tissues

1 reference

https://api.crossref.org/works/10.1016%2FS1053-2498%2802%2900474-6

7 January 2021

Prevention and treatment of cytomegalovirus disease in heart transplant patients

1 reference

https://api.crossref.org/works/10.1016%2FS1053-2498%2802%2900474-6

7 January 2021

A Controlled Trial of Ganciclovir to Prevent Cytomegalovirus Disease after Heart Transplantation

1 reference

https://api.crossref.org/works/10.1016%2FS1053-2498%2802%2900474-6

7 January 2021

Cytomegalovirus immune globulin prophylaxis in liver transplantation. A randomized, double-blind, placebo-controlled trial

1 reference

https://api.crossref.org/works/10.1016%2FS1053-2498%2802%2900474-6

7 January 2021

Passive immunization against cytomegalovirus in allograft recipients. The Rotterdam Heart Transplant Program experience

1 reference

https://api.crossref.org/works/10.1016%2FS1053-2498%2802%2900474-6

7 January 2021

Cytomegalovirus seronegative heart transplant recipients. Prophylactic use of anti-CMV immunoglobulin.

1 reference

https://api.crossref.org/works/10.1016%2FS1053-2498%2802%2900474-6

7 January 2021

Cytomegalovirus prophylaxis in solid organ transplant recipients

1 reference

https://api.crossref.org/works/10.1016%2FS1053-2498%2802%2900474-6

7 January 2021

Prospective randomized trial of efficacy of ganciclovir versus that of anti-cytomegalovirus (CMV) immunoglobulin to prevent CMV disease in CMV-seropositive heart transplant recipients treated with OKT3.

1 reference

https://api.crossref.org/works/10.1016%2FS1053-2498%2802%2900474-6

7 January 2021

Impact of cytomegalovirus hyperimmune globulin on outcome after cardiothoracic transplantation: a comparative study of combined prophylaxis with CMV hyperimmune globulin plus ganciclovir versus ganciclovir alone

1 reference

https://api.crossref.org/works/10.1016%2FS1053-2498%2802%2900474-6

7 January 2021

Is the incidence of cytomegalovirus disease following heart transplantation decreased by prophylactic ganciclovir and CMV-hyperimmunglobulin?

1 reference

https://api.crossref.org/works/10.1016%2FS1053-2498%2802%2900474-6

7 January 2021

Infection in organ-transplant recipients

1 reference

https://api.crossref.org/works/10.1016%2FS1053-2498%2802%2900474-6

7 January 2021

Prevention of cytomegalovirus disease in recipients of solid-organ transplants

1 reference

https://api.crossref.org/works/10.1016%2FS1053-2498%2802%2900474-6

7 January 2021

Potential role of human cytomegalovirus and p53 interaction in coronary restenosis

1 reference

https://api.crossref.org/works/10.1016%2FS1053-2498%2802%2900474-6

7 January 2021

Impact of prophylactic immediate posttransplant ganciclovir on development of transplant atherosclerosis: a post hoc analysis of a randomized, placebo-controlled study.

1 reference

https://api.crossref.org/works/10.1016%2FS1053-2498%2802%2900474-6

7 January 2021

Expression of herpes simplex virus ICP47 and human cytomegalovirus US11 prevents recognition of transgene products by CD8(+) cytotoxic T lymphocytes

1 reference

https://api.crossref.org/works/10.1016%2FS1053-2498%2802%2900474-6

7 January 2021

10.1016/S1053-2498(02)00474-6

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12633691%20AND%20SRC:MED&resulttype=core&format=json

release_6ifyrdlcvfgvzn4zc2xneoawou

1 November 2019

Fatcat ID

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/6ifyrdlcvfgvzn4zc2xneoawou

24 November 2022

mapped directly with Wikidata item

1 reference